trends qualifier – Page 2

Biotech Industry’s Turbulent Year: Fierce Biotech’s Top 10 Most-Read Stories of 2024

5 months ago talkbio0Tagged Biopharma, biotech industry, J.P. Morgan Healthcare, M&A, rejections, shutdowns, trends qualifier, United States Food and Drug Administration

Biotech industry, layoffs, site shutdowns, FDA rejections, M&A deals, J.P. Morgan Healthcare Conference, biopharma trends

Biopharmaceutical Manufacturing and Emerging Trends in 2024: A Global Outlook

5 months ago talkbio0Tagged 2024, Biopharmaceutical manufacturing, Biosimilars, Biotechnology, Cells, Drug Discovery, gene therapy, innovations, Precision Medicine, trends qualifier

Biopharmaceutical manufacturing, 2024 trends, personalized medicine, AI-driven drug discovery, biosimilars, cell and gene therapies, biotechnology innovations.

Roche’s Parkinson’s Drug Fails Second Mid-Stage Trial, Yet Shows Promising Trends

5 months ago talkbio0Tagged Clinical Trials, exploration, Failure (biologic function), Parkinson 's disease, Prasinezumab, Roche (company), trends qualifier

Roche, Parkinson’s disease, prasinezumab, clinical trial failure, promising trends, further exploration

2024 Biotech IPOs: Insights and Trends

5 months ago talkbio0Tagged 2024, biopharma sector, biotech, Capital, Health care facility, innovation, Investments, IPO, IPOs, public entity, trends qualifier, venture

Biotech IPOs, 2024 IPO trends, biopharma sector, initial public offerings, venture capital investment, healthcare innovation.

Healthcare M&A and IRA Price Negotiations: Key Trends to Watch Amidst Political Shifts

5 months ago talkbio0Tagged Acquisitions, Drug Industry, drug price, Healthcare M&A, Inflation, Ira (eukaryote), Mediation, Medicare, mergers, Negotiation Program, Prices, trends qualifier

Healthcare M&A, IRA Price Negotiations, Medicare Drug Price Negotiation Program, Inflation Reduction Act, Pharmaceutical Industry Trends, Mergers and Acquisitions Outlook 2024

Navigating JPM Week 2024: Insights and Opportunities in Biopharma

5 months ago talkbio0Tagged Biopharma, deal-making, Industry, Investments, IPOs, JPM, M&A, Network, regulatory, trends qualifier

JPM Week 2024, Biopharma, Industry Insights, Networking, Deal-making, Investment, M&A, IPOs, Regulatory Trends

CSL Behring to Close California R&D Site Amid Shift in Gene Therapy Strategy

6 months ago talkbio0Tagged Behring, California, ex vivo, gene therapy, Industry, R&D site closure, SMPX gene, strategic, trends qualifier

CSL Behring, California R&D site closure, ex vivo gene therapy, strategic repositioning, biotech industry trends

Healthcare Evolution 2025: AI, IRA, and GLP-1s Redefine the Industry

6 months ago talkbio0Tagged advancements, Aortic Valve Insufficiency, Biopharma, DNA Integration, Glucagon-Like Peptide 1, Health care facility, Healthcare technology, Impact food supplement, Ira (eukaryote), Pharmaceutical Industry Shifts, Telemedicine, trends qualifier, Value-Based Care

AI in Healthcare, IRA Impact on Biopharma, GLP-1 Medications, Healthcare Trends 2025, Value-Based Care, Telemedicine Integration, Pharmaceutical Industry Shifts, Healthcare Technology Advancements